Telzuit Medical Technologies, Inc. Demonstrates Bio-Patch At Medical Advisory Board Meeting In Washington, D.C.

ORLANDO, Fla., Dec. 5 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. (the “Company” or “Telzuit”) announced today that the Company has successfully demonstrated a working prototype of the Bio-Patch Wireless Heart Monitor (the “Bio-Patch”). The demonstration took place during the first formal meeting of the Company’s Medical Advisory Board on December 2, 2005, in Washington, D.C. The Medical Advisory Board is chaired by Dr. Ronald Berger, Co-Director of Cardiac Electrophysiology at Johns Hopkins Medical Institutions.

During the demonstration, cardiac data was transmitted from the wireless Bio-Patch to the accompanying PDA, and then transferred wirelessly back to the Company’s data center in Orlando, Florida. The data was then run through the Company’s IBM hardware and software, and Philips software algorithm to create a full, clinical quality 12-lead ECG. In addition to the demonstration, the Medical Advisory Board members engaged in active discourse on the science and application of the Bio-Patch. The Company expects to have its Bio-Patch Wireless Heart Monitor available to physicians in several states by the end of December 2005.

Donald Sproat, CEO and President of Telzuit Medical Technologies, Inc. was quoted as saying, “We are very pleased with the input and observations from our Medical Advisory Board, as well as with the product demonstration itself. We trust these fine physicians will continue to provide valuable feedback on our product as it relates to patient, physician, and other medical associated issues.”

Dr. Ronald Berger commented, “Telzuit has achieved enormous success in developing a wireless single-patch Holter system. I believe patients and physicians will find the system far more convenient and comfortable than existing Holters. The new paradigm of wireless Holters will likely revolutionize the marketplace for this important diagnostic modality.”

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The first step in this mission will initially take the form of our state-of-the-art, FDA approved, Bio-Patch Wireless Heart Monitor. This is a full 12-lead, completely wireless, Holter monitor, which is new to the marketplace. Telzuit anticipates that the product will be available to patients and physicians, and that the Company’s Cardiac Monitoring Center will open, by December 2005.

Telzuit is also building its own dedicated intranet as a platform to handle several of the products it will be releasing, including its initial product, the Bio-Patch Wireless Heart Monitor. More information on Telzuit, its business model, and its products can be found on its website: http://www.telzuit.com.

The corporate offices of the Company are located at 5422 Carrier Drive, Suite 306, Orlando, FL 32819. Questions may be addressed to James Tolan, Senior Vice President of Business Development, at 407-354-1222.

Forward Looking Statement: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and actual results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact: Telzuit Medical Technologies, Inc, Orlando James Tolan, Senior VP 407-354-1222 Brainerd Communicators, Inc. Jennifer Gery (press) Todd St.Onge (investors) 212-986-6667

Telzuit Medical Technologies, Inc.

CONTACT: James Tolan, Senior VP of Telzuit Medical Technologies, Inc.,+1-407-354-1222; or press: Jennifer Gery, or investors: Todd St.Onge, bothof Brainerd Communicators, Inc., +1-212-986-6667